Dual immunological blockade in the treatment of metastatic non-small cell lung cancer: reality and perspectives

Nowadays immunotherapy is a crucial option in the treatment of non-small cell lung cancer. There are a lot of actual options of the first-line therapy for the patients with metastatic lung cancer, including dual immunological blockade of PD-1/PD-L1 and CTLA-4 pathways. This review is an attempt to c...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Denis I. Yudin, Konstantin K. Laktionov, Liudmila V. Laktionova, Valeriy V. Breder
Format: article
Langue:RU
Publié: IP Habib O.N. 2021
Sujets:
Accès en ligne:https://doaj.org/article/a92e51c914374d90b0dcf921ac158329
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!